This position will work with the Process Sciences teams to develop and characterize cell therapy manufacturing processes and products, focusing on allogeneic T-cell therapies. The Sr. Research Associate will be responsible for contributing to the process development of allogeneic T-cell therapies to enable clinical trials. Under minimal supervision, you will be expected to design and perform experiments, organize, and carefully document results, analyze and interoperate results, and communicate findings.
Reports to: Scientist, Process Development
Location: Aurora, CO
Primary Responsibilities
- Contribute to the development of manufacturing processes for allogeneic T-cell therapies.
- Executes studies to facilitate development of allogeneic T-cell therapy processes and enabling clinical trials.
- Executes process development studies to develop a thorough understanding of operating and performance parameters (Design space).
- Executes studies to develop process to obtain optimal cell characteristics to establish allogeneic CAR-T platform
- Incorporate scalable technologies
- Sets up, monitors, samples and analyzes cell culture processes.
- Performs multiplexed cell-based assays (killing assays, mixed lymphocyte reactions, proliferation assays, etc.) for process assessment and product characterization.
- Role model for Atara’s Values of patients first, innovation teamwork, community and mindset.
Qualifications:
Education and Experience:
- BS in Immunology, Biology, or engineering science with 2-5 years of related industry experience. Or M.S. with 1-3 years of related industry experience.
- Experience with the generation and evaluation of human CAR-T therapies; Industry experience in adoptive T cell, CAR-T, or TCR therapeutics preferred.
- Experience with process development, scale-up and/or technology transfer preferred
- Familiarity with development and /or commercialization of cell-based therapeutics
- Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities
More about Atara Bio:
We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.
Our mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork, and a commitment to excellence.”
Our vision – “T-Cell Immunotherapy for every patient, any time.”
Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.
We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States.
Source: Indeed.com
Click Here To Apply
